Clinical Trial Update: A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer [Phase 2]

View source ↗

Summary

Phase IIa clinical trial evaluating the efficacy and safety of 6MW3211 in patients with advanced lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• 6MW3211

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Advanced Lung Cancer | Phase 2 | Status: UNKNOWN